Azhar Ansari - Concepedia

Author

Azhar Ansari

Also Known As

A Ansari, A. ANSARI, A. Ansari, A. Moleirinho, A. R. Ansari, Abdul Khalique Ansari, Alya Ansari, Aulia Kamal Ansari, Azhar Ansari, Azhar Mohammed Ansari

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

St Thomas' Hospital The University of Queensland East Surrey Hospital Mater Health Services Guy's and St Thomas' NHS Foundation Trust

About

Azhar Ansari is an author at St Thomas' Hospital specializing in medicine, autoimmune disease, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	763
2	Natural Sciences	2	2	81
3	Allergy	2	2	58
4	Biochemistry	2	2	81
5	Gastroenterology	2	2	385

Azhar Ansari

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase) Anthony M. Marinaki, Azhar Ansari, John A. Duley, Pharmacogenetics InflammationDrug HypersensitivityInosine Triphosphate PyrophosphataseAnti-inflammatoryAutoimmune Disease	2004	322
Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency Satoshi Sumi, Anthony M. Marinaki, Monica Arenas, Human Genetics Genetic DisorderGeneticsBiochemical GeneticsMolecular BiologyMolecular Genetics	2002	267
Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease Azhar Ansari, Cesare Hassan, J. A. Duley, Alimentary Pharmacology & Therapeutics	2002	248
Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease Azhar Ansari, M Arenas, Simon Greenfield, Alimentary Pharmacology & Therapeutics	2008	164
Low‐dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease Azhar Ansari, Nisha Patel, Jeremy Sanderson, Alimentary Pharmacology & Therapeutics	2010	132
Long‐term outcome of using allopurinol co‐therapy as a strategy for overcoming thiopurine hepatotoxicity in treating inflammatory bowel disease Azhar Ansari, Tim Elliott, Bijay Baburajan, Alimentary Pharmacology & Therapeutics	2008	117
Novel pharmacogenetic markers for treatment outcome in azathioprine‐treated inflammatory bowel disease Melissa Smith, Anthony M. Marinaki, M Arenas, Alimentary Pharmacology & Therapeutics	2009	94
Mutation in the<i>ITPA</i>Gene Predicts Intolerance to Azathioprine Anthony M. Marinaki, J. A. Duley, M Arenas, Nucleosides Nucleotides & Nucleic Acids GeneticsImmunodeficienciesImmunologyGastroenterologyPathology	2004	63
Experience with the use of low-dose methotrexate for inflammatory bowel disease S. Y. Soon, Azhar Ansari, May M. C. Yaneza, European Journal of Gastroenterology & Hepatology	2004	57
Genetic determinants of the thiopurine methyltransferase intermediate activity phenotype in British Asians and Caucasians Anthony M. Marinaki, Monica Arenas, Zubair Khan, Pharmacogenetics	2003	55

Page 1